Unlock Exclusive Insider Products
Join now and receive discounts on your next purchase.
Pickup currently not available
NOT FOR HUMAN CONSUMPTION
Nicotinamide Adenine Dinucleotide (NAD+) is an essential coenzyme found in all living cells. It plays a fundamental role in various biological processes, including energy metabolism, DNA repair, cellular signaling, and aging. NAD+ exists in two forms:
NAD+ (oxidized form)
NADH (reduced form)
Maintaining optimal NAD+ levels is crucial for cellular health, metabolic efficiency, and potentially longevity.
NAD+ serves multiple critical biological functions:
NAD+ acts as a coenzyme in glycolysis and the tricarboxylic acid (TCA or Krebs) cycle, facilitating ATP production in mitochondria.
Conversion between NAD+ and NADH drives cellular respiration and energy production.
NAD+ is a substrate for Poly (ADP-ribose) polymerases (PARPs), enzymes critical for DNA damage detection and repair.
Supports genomic stability and reduces mutation accumulation.
NAD+ activates sirtuins (SIRT enzymes), proteins associated with longevity, cellular metabolism, and stress resistance.
Elevated NAD+ levels correlate with improved cellular resilience, anti-aging effects, and mitochondrial efficiency.
NAD+ regulates circadian gene expression through sirtuins and PARPs, influencing sleep-wake cycles, metabolism, and overall health.
Several factors contribute to declining NAD+ levels, particularly with aging:
Natural aging process: NAD+ levels steadily decrease with age.
Poor diet/nutrition: Inadequate dietary precursors (e.g., nicotinamide riboside, niacin).
Chronic inflammation and oxidative stress: Accelerate NAD+ consumption.
Sedentary lifestyle and metabolic disorders: Obesity, diabetes, metabolic syndrome further reduce NAD+ availability.
Increasing NAD+ levels is currently a major focus of research for several conditions and potential health benefits:
Animal studies show NAD+ supplementation extends lifespan, improves metabolic function, and enhances mitochondrial health.
Human trials underway to assess anti-aging effects.
Potential therapeutic role in Alzheimer's, Parkinson's, ALS, and other neurodegenerative conditions via improved mitochondrial function, reduced inflammation, and enhanced DNA repair.
Enhancing NAD+ can improve insulin sensitivity, glucose metabolism, and reduce symptoms of metabolic syndrome.
Preclinical and early human trials demonstrate improved metabolic biomarkers.
NAD+ may improve vascular health, reduce inflammation, and protect against atherosclerosis and heart failure.
Clinical studies are exploring its efficacy in heart disease and hypertension.
NAD+ elevation may enhance cognitive performance, reduce brain fog, and improve mood, potentially via enhanced neuronal energy production and reduced neuroinflammation.
NAD+ therapy is experimentally used in addiction treatment, reportedly reducing withdrawal symptoms and cravings.
NAD+ levels can be increased through several means:
Nicotinamide Riboside (NR)
Nicotinamide Mononucleotide (NMN)
Niacin (Nicotinic Acid) & Nicotinamide (Vitamin B3)
Exercise and caloric restriction: Naturally boost NAD+ levels.
Diet rich in NAD+ precursors: Dairy, fish, lean meats, green vegetables.
Intravenous NAD+ infusion therapy: Clinical trials and anecdotal reports in addiction recovery, fatigue, and anti-aging.
No established standardized dosage guidelines exist, but common experimental dosages for oral NAD+ precursors are as follows:
Supplement | Typical Experimental Dose (Oral) |
---|---|
Nicotinamide Riboside (NR) | 250–1000 mg/day |
Nicotinamide Mononucleotide (NMN) | 250–1000 mg/day |
Niacin/Nicotinamide (Vitamin B3) | 50–500 mg/day |
IV NAD+ therapy: Typically 500–1500 mg per infusion (clinical contexts only).
Overall, NAD+ precursors (NR, NMN, Vitamin B3) demonstrate good safety profiles:
Flushing (primarily with Niacin)
Mild gastrointestinal upset
Headaches (infrequent)
Long-term high-dose supplementation safety is not fully established.
Potential interference with methylation pathways at extremely high doses.
Generally safe under clinical supervision; some reports of mild flushing, headache, chest discomfort at higher infusion rates.
Contraindications:
Known hypersensitivity to supplements (e.g., niacin flush intolerance).
Precautions:
Patients with liver dysfunction or gout should exercise caution with niacin supplementation.
Long-term NAD+ supplementation safety is still under investigation.
NAD+ precursors (NR, NMN, Niacin) widely available as dietary supplements and considered safe in recommended dosages.
NAD+ IV infusion therapy typically provided in medical or licensed clinical settings.
Extensive preclinical (animal and cell-based) evidence supports NAD+’s therapeutic potential for aging, metabolic disorders, and neurodegeneration.
Human clinical trials ongoing: promising preliminary findings regarding safety, mitochondrial health improvement, and metabolic enhancements.
More robust, controlled human studies required to confirm efficacy, long-term safety, and optimal dosing.
Potential Benefits | Potential Risks and Limitations |
---|---|
Improved metabolic function and energy levels | Long-term safety data limited for very high doses |
Enhanced DNA repair and longevity pathways | Mild side effects (flushing, gastrointestinal upset) |
Neuroprotective and cognitive benefits | Optimal dosing and form not yet fully standardized |
Cardiovascular health and anti-inflammatory effects | Potential interactions with medications |
Long-term randomized controlled trials (RCTs) assessing NAD+’s role in human aging, lifespan, and healthspan.
Standardization of optimal dosage, timing, and formulation for various therapeutic indications.
Clarifying mechanisms of NAD+ in neuroprotection, anti-aging, and mitochondrial support.
NAD+ is an essential coenzyme with promising therapeutic potential across aging, metabolic health, neurodegeneration, cardiovascular disease, and cognitive support. Early human studies support its safety and potential efficacy; however, robust clinical trials are required to fully elucidate optimal dosage, long-term safety, and precise therapeutic roles. Current evidence strongly supports NAD+ as a promising area of ongoing medical research, particularly in the context of aging, longevity, and metabolic health.
Rajman, L., Chwalek, K., & Sinclair, D.A. (2018). "Therapeutic potential of NAD-boosting molecules: the in vivo evidence." Cell Metabolism, 27(3), 529–547.
Yoshino, J., Baur, J.A., & Imai, S.I. (2018). "NAD+ intermediates: the biology and therapeutic potential." Annual Review of Nutrition, 38, 279–301.
Verdin, E. (2015). "NAD+ in aging, metabolism, and neurodegeneration." Science, 350(6265), 1208–1213.
Disclaimer:
This product is for educational purposes only. NAD+ supplementation or therapies should always be discussed with qualified healthcare providers before initiation.